Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.75 USD
−70.69 M USD
110.32 M USD
40.70 M
About Arcellx, Inc.
Sector
Industry
CEO
Rami Elghandour
Website
Headquarters
Gaithersburg
Founded
2014
FIGI
BBG00QHJM4S9
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ACLX is 90.44 USD — it has increased by 3.69% in the past 24 hours. Watch Arcellx, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Arcellx, Inc. stocks are traded under the ticker ACLX.
ACLX stock has fallen by −4.71% compared to the previous week, the month change is a 0.53% rise, over the last year Arcellx, Inc. has showed a 71.26% increase.
We've gathered analysts' opinions on Arcellx, Inc. future price: according to them, ACLX price has a max estimate of 134.00 USD and a min estimate of 73.00 USD. Watch ACLX chart and read a more detailed Arcellx, Inc. stock forecast: see what analysts think of Arcellx, Inc. and suggest that you do with its stocks.
ACLX reached its all-time high on Nov 12, 2024 with the price of 107.37 USD, and its all-time low was 6.04 USD and was reached on May 17, 2022. View more price dynamics on ACLX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ACLX stock is 6.31% volatile and has beta coefficient of 2.31. Track Arcellx, Inc. stock price on the chart and check out the list of the most volatile stocks — is Arcellx, Inc. there?
Today Arcellx, Inc. has the market capitalization of 4.89 B, it has decreased by −0.69% over the last week.
Yes, you can track Arcellx, Inc. financials in yearly and quarterly reports right on TradingView.
Arcellx, Inc. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ACLX earnings for the last quarter are −0.48 USD per share, whereas the estimation was −0.31 USD resulting in a −55.00% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Arcellx, Inc. earnings.
Arcellx, Inc. revenue for the last quarter amounts to 26.03 M USD, despite the estimated figure of 38.73 M USD. In the next quarter, revenue is expected to reach 25.47 M USD.
ACLX net income for the last quarter is −25.87 M USD, while the quarter before that showed −27.20 M USD of net income which accounts for 4.91% change. Track more Arcellx, Inc. financial stats to get the full picture.
No, ACLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 130.00 employees. See our rating of the largest employees — is Arcellx, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Arcellx, Inc. EBITDA is −65.30 M USD, and current EBITDA margin is −79.62%. See more stats in Arcellx, Inc. financial statements.
Like other stocks, ACLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Arcellx, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Arcellx, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Arcellx, Inc. stock shows the buy signal. See more of Arcellx, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.